Whalegun
Home

AbbVie ABBV paid Brownstein Hyatt Farber Schreck $60K for lobbying in Q3 2023 · Health Issues

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q3 2023
Stock
AbbVie ABBV
Client
Abbvie
Reported
23/10/18

Up 0.0% from last quarter

What else happened in AbbVie around then

Filed or reported within 30 days of the trade day · 23/08/31~23/10/30

Abbvie's other lobbying reports

  • Abbvie

    LobbyingAbbVie

    $50K

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $60K

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $1.2M

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $60K

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $30K

    Reported 07/20

AbbVie ABBV paid Brownstein Hyatt Farber Schreck $60K for lobbying in Q3 2023 · Health Issues | Whalegun